Skip to content

Trauma-Focused Equine-Assisted Therapy (TF-EAT) for Veterans With PTSD

Trauma-Focused Equine-Assisted Therapy (TF-EAT) for Veterans With PTSD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03068325
Acronym
TF-EAT
Enrollment
63
Registered
2017-03-01
Start date
2016-04-30
Completion date
2019-12-31
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder

Brief summary

This study seeks to examine feasibility, acceptability, safety, and preliminary efficacy of Equine-Assisted Therapy for veterans with posttraumatic stress disorder (EAT-PTSD). While several well-studied, validated treatments for PTSD exist, some individuals find these treatments ill-suited, ineffective, or undesirable. EAT is an alternative therapy widely used by organizations, such as PATH International Equine Services, that endorse its effectiveness for treating a variety of mental health issues. These claims have drawn criticism because the published research contains glaring methodological flaws, making it difficult to assess how effective these therapies actually are (Anestis et al., 2014). Equine-assisted therapies present a unique treatment modality that might effectively treat PTSD, particularly for individuals who have difficulty with other treatment modalities. In EAT, a psychotherapist and equine specialist work together to help the patients negotiate interactions with a horse using structured interventions or activities.

Detailed description

In this pilot study the investigators will develop the EAT intervention and determine whether research methods (evaluation interviews, assessment measures, videotaping procedures) are acceptable to participants. Specifically, the investigators will focus on issues such as session length, appropriateness of the content for treatment of PTSD, ordering of session content, adherence to the manual of the equine therapeutic team (based on observations made during supervision and feedback from the consultants), and will detail logistics of data collection and how best to record the sessions (camera angles, etc.).

Interventions

OTHEREAT-PTSD

Sponsors

Columbia University
CollaboratorOTHER
Research Foundation for Mental Hygiene, Inc.
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 18 and 70 * Current DSM-5 diagnosis of PTSD as determined by a) full criteria met on CAPS, and b) clinical assessment * Able to give consent, fluent in English

Exclusion criteria

* History of psychiatric diagnosis of psychotic disorder, unstable bipolar disorder * Elevated depression of clinical concern and/or score of \>25 on the Hamilton Rating Scale for Depression * At elevated risk for suicide based on history and current mental state * History of substance/alcohol use disorder at severe level within the past six months, and current diagnosis of substance/alcohol use disorder at a moderate level within past two months * Fear of horses or other large animals * Orthopedic or other physical conditions and/or limitations that prevent people from walking unassisted and/or walking freely in the ring.

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Clinician-Administered PTSD Scale at 8 Weeks8 weeksChange in symptoms of PTSD as assessed by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5, severity rating ranging from 0-80 with higher scores indicating more severe PTSD) in a clinical interview

Countries

United States

Participant flow

Pre-assignment details

Ninety-seven individuals were assessed for eligibility in the study, but 34 were excluded as a result of not meeting study inclusion criteria, leaving 63 participants to proceed into study enrollment.

Participants by arm

ArmCount
EAT-PTSD
Manualized EAT-PTSD seeks to increase affective awareness of self and others, improve communication, help regulate emotional response, improve critical thinking/problem solving, and increase self-confidence/self-efficacy while engaging with the horses.
63
Total63

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up5

Baseline characteristics

CharacteristicEAT-PTSD
Age, Continuous50.01 years
STANDARD_DEVIATION 12.38
Index Trauma
Child abuse
23 Participants
Index Trauma
Combat-related
27 Participants
Index Trauma
Military sexual trauma
23 Participants
Index Trauma
Natural disaster
1 Participants
Index Trauma
Other
16 Participants
Index Trauma
Physical assault
9 Participants
Index Trauma
Sexual assault
1 Participants
Index Trauma
Traumatic accident
4 Participants
Index Trauma
Traumatic sudden loss
7 Participants
Military Conflicts
None
25 Participants
Military Conflicts
OEF/OIF
23 Participants
Military Conflicts
Other
5 Participants
Military Conflicts
Vietnam/Korea
10 Participants
Race/Ethnicity, Customized
Black/African-American
26 Participants
Race/Ethnicity, Customized
Other
15 Participants
Race/Ethnicity, Customized
Prefer not to respond
6 Participants
Race/Ethnicity, Customized
White
16 Participants
Service Era
1960-1969
6 Participants
Service Era
1970-1979
14 Participants
Service Era
1980-1989
20 Participants
Service Era
1990-1999
20 Participants
Service Era
2000-2009
31 Participants
Service Era
2010-2019
15 Participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
40 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 63
other
Total, other adverse events
0 / 63
serious
Total, serious adverse events
0 / 63

Outcome results

Primary

Change From Baseline in Clinician-Administered PTSD Scale at 8 Weeks

Change in symptoms of PTSD as assessed by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5, severity rating ranging from 0-80 with higher scores indicating more severe PTSD) in a clinical interview

Time frame: 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
EAT-PTSDChange From Baseline in Clinician-Administered PTSD Scale at 8 WeeksBaseline38.6 score on a scaleStandard Deviation 8.1
EAT-PTSDChange From Baseline in Clinician-Administered PTSD Scale at 8 Weeks8 weeks26.9 score on a scaleStandard Deviation 12.4

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026